News
As in previous studies, the SHIELD study found health care workers who received the Novavax vaccine reported significantly ...
Novavax (NasdaqGS:NVAX) recently announced promising preliminary results from the SHIELD-Utah study, which highlighted fewer and less severe reactogenicity symptoms for its COVID-19 Vaccine, ...
Health secretary Robert F. Kennedy Jr. has expressed another unorthodox view on vaccines, declaring that single antigen ...
Novavax (NVAX) announced preliminary results from the SHIELD-Utah study that showed Novavax’s COVID-19 Vaccine, Adjuvanted 2024-2025 Formula ...
The health secretary has chipped away at the idea that immunizing children against measles and other diseases is a public ...
The decline in Novavax stock follows the HHS Secretary's concerns regarding the efficacy of its protein-based COVID-19 ...
An advisory panel on vaccines meets, carefully, in the shadow of a health secretary who has often criticized it.
Pfizer Inc.'s stock is trading at $22 with an 8% dividend yield, driven by market fears over losing vaccine revenues. Read ...
Shares in US biotech Novavax fell more than 20% before the weekend, following remarks from health and human services ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results